Trials / Completed
CompletedNCT00561769
Luteal Phase Commencing of Growth Hormone
Growth Hormone co-Treatment Within a GnRH Agonist Long Protocol in Patients With Poor Ovarian Response
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 61 (actual)
- Sponsor
- Gulhane School of Medicine · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Commencing of growth hormone in luteal phase when follicular cohort for the next cycle is being gathered may increase mature oocytes in poor responder
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Norditropin pen | 12 IU per day |
Timeline
- Start date
- 2005-01-01
- Completion
- 2007-11-01
- First posted
- 2007-11-21
- Last updated
- 2007-11-21
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT00561769. Inclusion in this directory is not an endorsement.